Navigation Links
Can Obama Plan Tackle Diabetes Crisis? Epinex Test Could Help
Date:3/10/2009

IRVINE, Calif., March 10 /PRNewswire/ -- Diabetes will be a huge burden on President Obama's $634 billion plan to expand and improve healthcare coverage. Epinex Diagnostics, a private biomedical company located in Irvine, California, has developed a new diabetes monitoring device that could relieve the burden of diabetes on our healthcare system.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090310/LA81722)

The Epinex G1A(TM) Rapid Diabetes Monitoring Index Test is a revolutionary monthly rapid test that uses glycated albumin to measure how much damage has been done to the body by excess sugar. The Epinex G1A(TM) test will be a significant asset to help keep costs down by introducing a monthly testing paradigm that has been proven effective. This test could allow doctors to take action sooner than current diabetes testing methods, reducing the severity and cost of diabetes and its complications, which include blindness, kidney failure and cardiac disease.

President Obama recently acknowledged, "crushing health care costs...drag down our economy, bankrupt our families, and represent the fastest-growing part of our budget." In an unprecedented commitment to a new, more effective approach to healthcare, the President has taken the challenge to keep raging costs under control by proposing the "largest investment ever" in preventive care.

Diabetes eats up an enormous chunk of our current healthcare resources. It has become the greatest healthcare crisis of our time, affecting one in three Americans. Last year alone, direct medical costs for diabetes totaled $116 billion, a 32% increase since 2002. Despite current efforts to manage the epidemic, the toll of diabetes continues to spiral out of control. However, pouring more resources into ineffective programs will only waste money.

Continuing to address the diabetes epidemic using methods of the past threatens to set up our health care system for failure. "The current treatment paradigm for diabetes doesn't work," explains Epinex CEO, Asad Zaidi. "With our current financial crisis, Epinex is working on a product that will help save our already over-burdened healthcare system billions of dollars, while helping diabetics manage their disease more effectively."

About Epinex Diagnostics, Inc.

Epinex Diagnostics is a privately owned medical device company with a vision to help alleviate the current healthcare crisis through the development of innovative point-of-care technologies using rapid diagnostic tests. Please find further information about the company and the G1A(TM) test at www.epinex.com.


'/>"/>
SOURCE Epinex Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cord Blood America Sees Significant Positives in President Obamas Lifting of Stem Cell Funding Restrictions
2. Environmental Tectonics Corporations BioMedical Divisions Hyperbaric Chambers Address U.S. President Obamas Initiative to Computerize Medical Records
3. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
4. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
5. Cord Blood America Salutes President-Elect Obamas Promise to Lift Restrictions on Stem Cell Research
6. McCain and Obama on Bio-threat Detection and Pandemic Response: QualSec Weighs in
7. Old and new therapies combine to tackle atherosclerosis
8. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
9. New Report Tackles the Changing Landscape for Alzheimers Diagnostics and Treatments
10. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
11. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... the international market with three research projects accepted for presentation at the 33rd ... . Nearly 10,000 participants – including some of the world’s top thought leaders ...
(Date:6/27/2017)... ... June 27, 2017 , ... The recent vote by the ... a disease gives new hope to patients and hopefully sheds new light on the ... M.D. , an infertility expert and founding partner of Texas Fertility Center . ...
(Date:6/27/2017)... Iowa (PRWEB) , ... June 27, 2017 , ... ... technology license agreement whereby DuPont gains exclusive rights to the ERS patent portfolio ... ERS was formed to commercialize the foundational intellectual property (IP) of the CRISPR-Cas ...
(Date:6/23/2017)... ... June 23, 2017 , ... Biova, LLC., the leader in water ... Board of Directors. Dr. Henig will bring a wealth of scientific experience in the ... the Chief Technical and Scientific Officer of four major global companies in the last ...
Breaking Biology Technology:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):